Next Article in Journal
Restoring Balance: Probiotic Modulation of Microbiota, Metabolism, and Inflammation in SSRI-Induced Dysbiosis Using the SHIME® Model
Previous Article in Journal
Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and GLP-1 RAs
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Rania et al. Efficacy and Safety of Intra-Articular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis. Pharmaceuticals 2025, 18, 302

1
Operative Unit of Pharmacology and Pharmacovigilance, “Renato Dulbecco” University Hospital, 88100 Catanzaro, Italy
2
Research Center FAS@UMG, Department of Health Science, University Magna Graecia, 88100 Catanzaro, Italy
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2025, 18(8), 1131; https://doi.org/10.3390/ph18081131
Submission received: 17 July 2025 / Accepted: 17 July 2025 / Published: 29 July 2025

Text Correction

In the original publication [1], there was an error in the Discussion section. The sentence originally stated:
“In our study, we excluded patients with a Body Mass Index lower than 29 kg/m2…”
This has been corrected to:
“In our study, we enclosed only patients with a Body Mass Index lower than 29 kg/m2…”
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has been updated accordingly.

Reference

  1. Rania, V.; Marcianò, G.; Vocca, C.; Palleria, C.; Bianco, L.; Caroleo, M.C.; Gallelli, L. Efficacy and Safety of Intra-Articular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis. Pharmaceuticals 2025, 18, 302. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rania, V.; Marcianò, G.; Vocca, C.; Palleria, C.; Bianco, L.; Caroleo, M.C.; Gallelli, L. Correction: Rania et al. Efficacy and Safety of Intra-Articular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis. Pharmaceuticals 2025, 18, 302. Pharmaceuticals 2025, 18, 1131. https://doi.org/10.3390/ph18081131

AMA Style

Rania V, Marcianò G, Vocca C, Palleria C, Bianco L, Caroleo MC, Gallelli L. Correction: Rania et al. Efficacy and Safety of Intra-Articular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis. Pharmaceuticals 2025, 18, 302. Pharmaceuticals. 2025; 18(8):1131. https://doi.org/10.3390/ph18081131

Chicago/Turabian Style

Rania, Vincenzo, Gianmarco Marcianò, Cristina Vocca, Caterina Palleria, Luigi Bianco, Maria Cristina Caroleo, and Luca Gallelli. 2025. "Correction: Rania et al. Efficacy and Safety of Intra-Articular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis. Pharmaceuticals 2025, 18, 302" Pharmaceuticals 18, no. 8: 1131. https://doi.org/10.3390/ph18081131

APA Style

Rania, V., Marcianò, G., Vocca, C., Palleria, C., Bianco, L., Caroleo, M. C., & Gallelli, L. (2025). Correction: Rania et al. Efficacy and Safety of Intra-Articular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis. Pharmaceuticals 2025, 18, 302. Pharmaceuticals, 18(8), 1131. https://doi.org/10.3390/ph18081131

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop